Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

IE00BTN1Y115
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000BNWG87
MDT
Medtronic PLC
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Medical - Devices · THEMEFOLIO: $HLTH
NAME
Medtronic PLC
ISIN
IE00BTN1Y115
TICKER
MDT
MIC
XNYS
REUTERS
MDT.N
BLOOMBERG
MDT US
Do., 14.08.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Aug. 14, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 14, 2025, approved the company's cash dividend for the second quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 202...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 05.08.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Aug. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025, A news release containing summary financial information will be issue...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 05.08.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Aug. 5, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025, A news release containing summary financial information will be issued at ap...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mo., 21.07.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by individuals aged 2 years and older, during pregnancy, as well as type 2 insulin-requiring diabetes. To gain CE Mark...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 08.07.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing th...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mo., 23.06.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Comp...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 12.06.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 12.06.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, June 12, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Fr., 23.05.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, May 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025. Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. E...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Fr., 23.05.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, May 23, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025. Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT (10:...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 21.05.2025       Medtronic
IE00BTN1Y115

Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), whi...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mi., 21.05.2025       Medtronic
IE00BTN1Y115

Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, May 21, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ende...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mi., 21.05.2025       Medtronic
IE00BTN1Y115

Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management GALWAY, Ireland, May 21, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global le...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mi., 21.05.2025       Medtronic
IE00BTN1Y115

Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management GALWAY, Ireland, May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a gl...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 08.05.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, May 7, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 08.05.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be availa...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mi., 07.05.2025       Medtronic
IE00BTN1Y115

Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign GALWAY, Ireland, May 7, 2025 /PRNewswire/ -- A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
So., 27.04.2025       Medtronic
IE00BTN1Y115

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy (RF/PF), focal Sphere-9™ catheter demonstrates efficacy for linear ablation in persistent AFibMedtronic continues legacy of leadership in innovation,...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Sa., 26.04.2025       Medtronic
IE00BTN1Y115

Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration GALWAY, Ireland and LAS VEGAS, April 26, 202...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Fr., 25.04.2025       Medtronic
IE00BTN1Y115

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025: Late-breaking clinical study results evaluating the OmniaSecure lead for investigational use in the LBBAP location show high defibrillation success  GALWA...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 24.04.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an interoperable pump. FDA clearance of this pump would pave the way for system integration with a continuous...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Sa., 19.04.2025       Medtronic
IE00BTN1Y115

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync™ sensor for use with the MiniMed™ 780G system. With this approval, the MiniMed™...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
So., 30.03.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 27.03.2025       Medtronic
IE00BTN1Y115

Das Instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY wird ex Dividende/Zinsen gehandelt am 28.03.2025 The instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY has its ex-dividend/interest day on 28.03.2025...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mi., 26.03.2025       Medtronic
IE00BTN1Y115

Das Instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY wird cum Dividende/Zinsen gehandelt am 27.03.2025 und ex Dividende/Zinsen am 28.03.2025 The instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY has its pre-dividend/interest day on 27.03.2025 and its ex-dividend/interest day on 28.03.2025...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
So., 09.03.2025       Medtronic
IE00BTN1Y115

CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON, March 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 06.03.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mo., 24.02.2025       Medtronic
IE00BTN1Y115

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever  GALWAY, Ireland, Feb. 24, 2025 /PRNewswire/ -- For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global leader in healt...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 18.02.2025       Medtronic
IE00BTN1Y115

Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland, Feb. 18, 2025 /CNW/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025. Key Highli...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 18.02.2025       Medtronic
IE00BTN1Y115

Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland, Feb. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025. Key...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mi., 05.02.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Feb. 5, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at htt...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mi., 05.02.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 21.01.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Jan. 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for the company, effective March 3, 2025. He will report to Medtronic Chairman and Chief Executive Officer Geoff Martha and will join the Medtronic Execu...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mo., 13.01.2025       Medtronic
IE00BTN1Y115

National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressureMilestone is supported by large public health need and robust, long-term data from the SPYRAL-HTN global clinical programGALWAY, Ireland, Jan. 13, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthca...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mo., 13.01.2025       Medtronic
IE00BTN1Y115

European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease GALWAY, Ireland, Jan. 13, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced today CE (Conformité Européenne) Mark approval in the European Union...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mo., 06.01.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Jan. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025. Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions o...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mo., 06.01.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Jan. 6, 2025 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025. Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the c...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 26.12.2024       Medtronic
IE00BTN1Y115

Das Instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY wird ex Dividende/Zinsen gehandelt am 27.12.2024 The instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY has its ex-dividend/interest day on 27.12.2024...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 24.12.2024       Medtronic
IE00BTN1Y115

Das Instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY wird cum Dividende/Zinsen gehandelt am 24.12.2024 und ex Dividende/Zinsen am 27.12.2024 The instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY has its pre-dividend/interest day on 24.12.2024 and its ex-dividend/interest day on 27.12.2024...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 05.12.2024       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Dec. 5, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 202...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mi., 20.11.2024       Medtronic
IE00BTN1Y115

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clear...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 19.11.2024       Medtronic
IE00BTN1Y115

Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises:  TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, Nov. 19, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 19.11.2024       Medtronic
IE00BTN1Y115

Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises:  TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, Nov. 19, 2024 /CNW/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 05.11.2024       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2025 on Tuesday, November 19, 2024. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Di., 05.11.2024       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Nov. 5, 2024 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2025 on Tuesday, November 19, 2024. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at htt...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Fr., 01.11.2024       Medtronic
IE00BTN1Y115

The Symplicity ™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure  GALWAY, Ireland, Nov. 1, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted transitional pass-through (TPT) paym...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Mo., 28.10.2024       Medtronic
IE00BTN1Y115

Company commits to advancing clinical data for Symplicity™ with the SPYRAL Gemini clinical trial and expansion of the GSR-DEFINE clinical trial GALWAY, Ireland and WASHINGTON, Oct. 28, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new, long-term data from its SPYRAL HTN-ON MED clinical t...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Do., 24.10.2024       Medtronic
IE00BTN1Y115

First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheterHighly anticipated by electrophysiologists for its innovation and demonstrated safety and efficacy as well as improved workflow and short learning curveNow with two pulsed field ablation (PFA) offerings and a portfolio of electrophysiology...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Fr., 04.10.2024       Medtronic
IE00BTN1Y115

Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland, Oct. 4, 2024 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, no...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink
Fr., 04.10.2024       Medtronic
IE00BTN1Y115

Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland, Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2...
Zur Nachricht
Medtronic
Charts & Research Termsheets Terminal
Permalink